190 related articles for article (PubMed ID: 19099400)
1. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function.
Klawitter J; Bendrick-Peart J; Rudolph B; Beckey V; Klawitter J; Haschke M; Rivard C; Chan L; Leibfritz D; Christians U; Schmitz V
Chem Res Toxicol; 2009 Jan; 22(1):118-28. PubMed ID: 19099400
[TBL] [Abstract][Full Text] [Related]
2. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation.
Schmitz V; Klawitter J; Bendrick-Peart J; Schoening W; Puhl G; Haschke M; Klawitter J; Consoer J; Rivard CJ; Chan L; Tran ZV; Leibfritz D; Christians U
Nephron Exp Nephrol; 2009; 111(4):e80-91. PubMed ID: 19293597
[TBL] [Abstract][Full Text] [Related]
4. Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose.
Klawitter J; Haschke M; Kahle C; Dingmann C; Klawitter J; Leibfritz D; Christians U
Br J Clin Pharmacol; 2010 Aug; 70(2):241-51. PubMed ID: 20653677
[TBL] [Abstract][Full Text] [Related]
5. Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study.
Klawitter J; Klawitter J; Kushner E; Jonscher K; Bendrick-Peart J; Leibfritz D; Christians U; Schmitz V
J Proteome Res; 2010 Feb; 9(2):865-75. PubMed ID: 19994912
[TBL] [Abstract][Full Text] [Related]
6. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood.
Serkova NJ; Christians U
Ther Drug Monit; 2005 Dec; 27(6):733-7. PubMed ID: 16404806
[TBL] [Abstract][Full Text] [Related]
8. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial.
Franz S; Regeniter A; Hopfer H; Mihatsch M; Dickenmann M
Am J Kidney Dis; 2010 Feb; 55(2):335-43. PubMed ID: 19926370
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat.
Sereno J; Vala H; Nunes S; Rocha-Pereira P; Carvalho E; Alves R; Teixeira F; Reis F
J Physiol Pharmacol; 2015 Apr; 66(2):285-99. PubMed ID: 25903959
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
[TBL] [Abstract][Full Text] [Related]
11. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
[TBL] [Abstract][Full Text] [Related]
12. Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.
Pereira BJ; Castro I; Burdmann EA; Malheiros DM; Yu L
Braz J Med Biol Res; 2010 Aug; 43(8):737-44. PubMed ID: 20549136
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury.
Inman SR; Davis NA; Olson KM; Lukaszek VA; McKinley MR; Seminerio JL
Urology; 2003 Oct; 62(4):750-4. PubMed ID: 14550466
[TBL] [Abstract][Full Text] [Related]
14. Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.
Kamar N; Allard J; Ribes D; Durand D; Ader JL; Rostaing L
Clin Nephrol; 2005 Feb; 63(2):80-6. PubMed ID: 15730049
[TBL] [Abstract][Full Text] [Related]
15. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization.
Aicher L; Meier G; Norcross AJ; Jakubowski J; Varela MC; Cordier A; Steiner S
Biochem Pharmacol; 1997 Mar; 53(5):723-31. PubMed ID: 9113092
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy.
Serkova N; Litt L; James TL; Sadée W; Leibfritz D; Benet LZ; Christians U
J Pharmacol Exp Ther; 1999 May; 289(2):800-6. PubMed ID: 10215655
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation.
Wyzgal J; Paczek L; Senatorski G; Zygier J; Rowiński W; Szmidt J; Perkowska A
Transplant Proc; 2002 Dec; 34(8):3185-7. PubMed ID: 12493414
[No Abstract] [Full Text] [Related]
18. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain.
Serkova N; Jacobsen W; Niemann CU; Litt L; Benet LZ; Leibfritz D; Christians U
Br J Pharmacol; 2001 Jul; 133(6):875-85. PubMed ID: 11454661
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
Satyanarayana PS; Chopra K
Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
[TBL] [Abstract][Full Text] [Related]
20. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
